SIENTRA INC

Sientra Inc. specializes in the design, development, and manufacturing of advanced surgical implants and medical devices, with a focused expertise in breast reconstruction and tissue expansion systems. The company delivers FDA-regulated, biocompatible implants, tissue expanders, and surgical prosthetics that meet stringent clinical and regulatory standards for reconstructive and post-mastectomy applications. Their technical capabilities encompass precision biomaterial engineering, implant surface modulation, and anatomically informed device design, ensuring compatibility with complex soft tissue environments. Sientra’s differentiation lies in its end-to-end control over the product lifecycle—from R&D and sterilization to clinical validation and supply chain reliability—enabling consistent delivery of high-integrity medical devices for sensitive surgical use. The contractor maintains a strong, sustained relationship with the Department of Veterans Affairs, supplying critical reconstructive implants and tissue expansion systems to support veteran healthcare needs, particularly in post-oncology and trauma recovery pathways. A single contract with the Department of Defense further demonstrates their capability to meet military medical standards, providing devices for use at naval medical centers in operational and rehabilitative settings. Sientra operates primarily within NAICS 339112 and 339113, focusing on the manufacturing of surgical instruments and medical appliances used in reconstructive surgery. Their vertical specialization in breast implant systems positions them as a niche provider within the broader medical device sector, serving both clinical and defense medical communities requiring precision-engineered, patient-specific solutions. As a privately held entity based in Irvine, California, Sientra Inc. maintains a streamlined operational structure with no federal certifications on record. Their geographic presence and manufacturing infrastructure are centered in Southern California, supporting rapid response and quality control for federal medical supply chains.